releases: https://walden.house.gov/media-center/press-releases/greg-walden-hold-hearing-drug-distributors-following-year-long
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://walden.house.gov/media-center/press-releases/greg-walden-hold-hearing-drug-distributors-following-year-long | Greg Walden to hold hearing with drug distributors following year-long bipartisan investigation into alleged pill dumping | 2018-05-07 | 2018 | 2018-05 | Republican | House | OR | Greg Walden | W000791 | walden.house.gov | legacy | Greg Walden to hold hearing with drug distributors following year-long bipartisan investigation into alleged pill dumping WASHINGTON, D.C. --Rep. Greg Walden (R-Hood River), Chairman of the House Energy and Commerce Committee, will hold a hearing with the leadership of national and regional drug distributors in regards to the committee's bipartisan investigation into opioid distribution practices, particularly alleged pill dumping in West Virginia. The hearing will be held tomorrow, May 8, 2018, at 10 a.m. ET. The hearing is entitled, Combating the Opioid Epidemic: Examining Concerns About Distribution and Diversion. The hearing falls on the one-year anniversary of the committee's initial requests for information regarding distribution practices in West Virginia. Walden's Energy and Commerce Committee has confirmed the following witnesses will testify: Mr. John Hammergren, Chairman, President and CEO, McKesson Corporation; Mr. George Barrett, Executive Chairman of the Board, Cardinal Health Inc.; Mr. Steven Collis, Chairman, President and CEO, AmerisourceBergen Corporation; Dr. Joseph Mastandrea, Chairman of the Board, Miami-Luken, Inc.; and Mr. J. Christopher Smith, former President and CEO, H.D. Smith Wholesale Drug Company. Walden, along with a bipartisan group of committee leaders, first requested information from the nation's top three distributors -- AmerisourceBergen, Cardinal Health, and McKesson -- on May 8, 2017. In September 2017, the committee probed a fourth distributor, Miami-Luken. In January 2018, the committee sent a follow-up letter to Miami-Luken and probed a fifth distributor, H.D. Smith. In February 2018, the committee sent follow-up questions to AmerisourceBergen, Cardinal Health, and McKesson. For a full timeline of the committee's bipartisan investigation, click here. The hearing was first announced on April 12, 2018. For more information on tomorrow's hearing, please click here. ### | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |